{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-054707","form_type":"8-K","ticker":"LONA","cik":"0001620463","company_name":"LeonaBio, Inc.","filed_at":"2025-04-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.077679+00:00","generated_at":"2026-05-23T13:26:41.784620+00:00","sec_items":["3.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Athira Pharma transfers to Nasdaq Capital Market; must regain $1 bid price by Oct 13, 2025","bullets":["Approved transfer from Nasdaq Global Select Market to Capital Market effective April 17, 2025.","Failed to meet $1 minimum bid price; granted 180-day grace period until October 13, 2025.","Must have bid price ≥ $1 for ten consecutive business days during grace period to regain compliance.","Seeking stockholder approval for reverse stock split at its 2025 annual meeting.","Stock continues trading under symbol 'ATHA' on Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-054707","json":"https://secwatch.observer/filing/0000950170-25-054707.json","markdown":"https://secwatch.observer/filing/0000950170-25-054707.md","text":"https://secwatch.observer/filing/0000950170-25-054707.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1620463/000095017025054707/0000950170-25-054707-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1620463/000095017025054707/atha-20250415.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T13:26:41.784620+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}